Claus-Peter Schneider
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Polyomavirus and related diseases
-
- Lung Cancer Treatments and Mutations
- Occupational and environmental lung diseases
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Metastasis and carcinoma case studies 2
- Oncology 6
- Lung Cancer Research Studies 3
- Cancer Diagnosis and Treatment 2
- Co-authors
- K. Höffken (3 shared papers)R. Kath (2 shared papers)Ulrich Pachmann (1 shared paper)Joachim H. Clement (1 shared paper)Oumar Camara (1 shared paper)Katharina Pachmann (1 shared paper)Martin Reck (3 shared papers)Lucio Crinò (2 shared papers)
- Journals
- Journal of Thoracic Oncology (4 papers)Journal of Clinical Oncology (4 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Clinical Lung Cancer (2 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Claus-Peter Schneider
20 papers receiving 632 citations
Peers
Comparison fields: 5 of 60
- Oncology 319
- Pulmonary and Respiratory Medicine 280
- Cancer Research 91
- Endocrinology, Diabetes and Metabolism 47
- Biophysics 13
Countries citing papers authored by Claus-Peter Schneider
This map shows the geographic impact of Claus-Peter Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus-Peter Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus-Peter Schneider more than expected).
Fields of papers citing papers by Claus-Peter Schneider
This network shows the impact of papers produced by Claus-Peter Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus-Peter Schneider. The network helps show where Claus-Peter Schneider may publish in the future.
Co-authors
The 25 scholars most cited alongside Claus-Peter Schneider, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 130 | |
| 2 | 2011 | 115 | |
| 3 | 2008 | 89 | |
| 4 | 2011 | 52 | |
| 5 | 2000 | 50 | |
| 6 | 2003 | 46 | |
| 7 | 2012 | 40 | |
| 8 | 1999 | 40 | |
| 9 | 2013 | 24 | |
| 10 | 2014 | 20 | |
| 11 | 2014 | 16 | |
| 12 | 2017 | 8 | |
| 13 | 2013 | 6 | |
| 14 | 2012 | 4 | |
| 15 | 2006 | 4 | |
| 16 | 2013 | 3 | |
| 17 | 2003 | 2 | |
| 18 | 1985 | 2 | |
| 19 | 2010 | 1 | |
| 20 | 2007 | 1 |
About Claus-Peter Schneider
Claus-Peter Schneider is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Epidemiology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 20 papers that have together received 653 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Research Studies (3 papers), Neuroendocrine Tumor Research Advances (2 papers), Cancer Diagnosis and Treatment (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Metastasis and carcinoma case studies (2 papers), Cancer Mechanisms and Therapy (1 paper) and Diabetes and associated disorders (1 paper). The work is most often cited by research in Oncology (319 citations), Pulmonary and Respiratory Medicine (280 citations), Cancer Research (91 citations), Endocrinology, Diabetes and Metabolism (47 citations) and Biophysics (13 citations). Claus-Peter Schneider has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include K. Höffken, R. Kath, Ulrich Pachmann, Joachim H. Clement, Oumar Camara, Katharina Pachmann, Martin Reck, Lucio Crinò, Jens Fiehler and Martin Reck. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Journal of Cancer Research and Clinical Oncology, Clinical Lung Cancer and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.